Cell therapy in Huntington disease

Area of Science:

• Neuroscience
• Genetics
• Regenerative Medicine

Background:

• Huntington disease (HD) is a progressive neurodegenerative disorder caused by polyglutamine expansions in the huntingtin protein.
• It leads to neuronal dysfunction and degeneration, causing significant motor, cognitive, and emotional impairments.
• Current research focuses on cell therapy to protect or replace vulnerable neurons.

Purpose of the Study:

• To explore cell therapy strategies for Huntington disease (HD).
• To evaluate approaches including endogenous stem cell manipulation, cell transplantation, and neurotrophic factor administration.
• To understand the potential of these strategies in preclinical models and inform future clinical translation.

Main Methods:

• Review of existing research on cell therapy approaches for HD.
• Analysis of strategies involving endogenous stem cell manipulation and neurogenesis.
• Examination of fetal and stem cell transplantation for cell replacement.
• Assessment of neurotrophic factor administration for neuronal protection.

Main Results:

• Cell therapy approaches have demonstrated promising outcomes in animal models of HD.
• Striatal transplantation of fetal-derived cells has been clinically assessed since the 1990s.
• Many cell therapy strategies are still in preclinical stages and not yet applied in clinical settings.

Conclusions:

• Cell therapy holds potential for treating Huntington disease (HD) by protecting or replacing neurons.
• Further understanding of HD pathophysiology and cell responses is crucial for successful clinical application.
• Developing robust frameworks is essential to determine the efficacy of these therapeutic strategies.